Zvibel I, Halay E, Reid L M
Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York 10461.
Mol Cell Biol. 1991 Jan;11(1):108-16. doi: 10.1128/mcb.11.1.108-116.1991.
Highly sulfated, heparinlike species of heparan sulfate proteoglycans, with heparinlike glycosaminoglycan chains, are extracellular matrix components that are plasma membrane bound in growth-arrested liver cells. Heparins were found to inhibit the growth and lower the clonal growth efficiency of HepG2, a minimally deviant, human hepatoma cell line. Heparan sulfates, closely related glycosaminoglycans present in the extracellular matrix around growing liver cells, had no effect on the growth rate or clonal growth efficiency of HepG2 cells. Neither heparins nor heparan sulfates had any effect on the growth rate or clonal growth efficiency of two poorly differentiated, highly metastatic hepatoma cell lines, SK-Hep-1 and PLC/PRF/5. Heparin's inhibition of growth of HepG2 cells correlated with changes in the mRNA synthesis and abundance of insulinlike growth factor II (IGF II) and transforming growth factor beta (TGF beta). HepG2 cells expressed high basal levels of mRNAs encoding IGF II and TGF beta that were inducible, through transcriptional and posttranscriptional mechanisms, to higher levels by specific heparin-hormone combinations. For both IGF II and TGF beta, the regulation was multifactorial. Transcriptionally, IGF II was regulated by the additive effects of insulin, glucagon, and growth hormone in combination with heparin; TGF beta was regulated primarily by the synergistic effects of insulin and growth hormone in combination with heparin. Posttranscriptionally, the mRNA abundance of the IGF II 4.5- and 3.7-kb transcripts was affected by insulin. Heparin induction of all IGF II transcripts was also dependent on triiodotyronine and prolactin, but it is unknown whether their induction by heparin was via transcriptional or posttranscriptional mechanisms. Heparin-insulin combinations regulated TGF beta posttranscriptionally. The poorly differentiated hepatoma cell lines PLC/PRF/5 and SK-Hep-1 either did not express or constitutively expressed low basal levels of IGF I, IGF II, and TGF beta, whose mRNA synthesis and abundance showed no response to any heparin-hormone combination. We discuss the data as evidence that matrix chemistry is a variable determining the expression of autocrine growth factor genes and the biological responses to them.
硫酸乙酰肝素蛋白聚糖的高度硫酸化、类肝素物种,带有类肝素糖胺聚糖链,是细胞外基质成分,在生长停滞的肝细胞中与质膜结合。已发现肝素可抑制HepG2(一种低度变异的人肝癌细胞系)的生长并降低其克隆生长效率。硫酸乙酰肝素是存在于生长中的肝细胞周围细胞外基质中的密切相关的糖胺聚糖,对HepG2细胞的生长速率或克隆生长效率没有影响。肝素和硫酸乙酰肝素对两种低分化、高转移性肝癌细胞系SK-Hep-1和PLC/PRF/5的生长速率或克隆生长效率均无任何影响。肝素对HepG2细胞生长的抑制作用与胰岛素样生长因子II(IGF II)和转化生长因子β(TGFβ)的mRNA合成及丰度变化相关。HepG2细胞表达高水平的编码IGF II和TGFβ的基础mRNA,通过转录和转录后机制,特定的肝素-激素组合可将其诱导至更高水平。对于IGF II和TGFβ,这种调节是多因素的。在转录方面,IGF II受胰岛素、胰高血糖素和生长激素与肝素联合的累加效应调节;TGFβ主要受胰岛素和生长激素与肝素联合的协同效应调节。在转录后方面,IGF II 4.5 kb和3.7 kb转录本的mRNA丰度受胰岛素影响。肝素对所有IGF II转录本的诱导也依赖于三碘甲状腺原氨酸和催乳素,但尚不清楚它们被肝素诱导是通过转录还是转录后机制。肝素-胰岛素组合在转录后调节TGFβ。低分化肝癌细胞系PLC/PRF/5和SK-Hep-1要么不表达,要么组成性表达低水平的基础IGF I、IGF II和TGFβ,其mRNA合成及丰度对任何肝素-激素组合均无反应。我们将这些数据作为证据进行讨论,即基质化学是决定自分泌生长因子基因表达及其生物学反应的一个变量。